EFFECTS OF THE NEW POTENT NONPEPTIDAL CCK RECEPTOR ANTAGONIST L-364,718 IN 2 DIFFERENT MODELS OF ACUTE-PANCREATITIS (AP)

被引：0
|
作者：
NIEDERAU, C
NIEDERAU, M
STROHMEYER, G
FERRELL, LD
GRENDELL, JH
机构：
[1] UNIV DUSSELDORF,DEPT MED,D-4000 DUSSELDORF 1,FED REP GER
[2] UNIV DUSSELDORF,DEPT PATHOL,D-4000 DUSSELDORF 1,FED REP GER
[3] UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143
来源：
DIGESTION | 1987年 / 38卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：45 / 46
页数：2
相关论文
共 43 条
  • [31] COMPARISON OF THE ACTION OF THE CCK-RECEPTOR ANTAGONISTS LOXIGLUMIDE AND L-364,718 AND OF THE M1-RECEPTOR ANTAGONIST TELENZEPINE ON THE PANCREATIC PROTEIN RESPONSE TO INTESTINAL TRYPTOPHAN
    TEYSSEN, S
    NIEBERGALL, E
    WETZEL, D
    BEGLINGER, C
    SINGER, MV
    GASTROENTEROLOGY, 1995, 108 (04) : A396 - A396
  • [32] EFFECTS OF THE CCK RECEPTOR ANTAGONIST L364,718 ON THE PANCREATIC EXOCRINE RESPONSE TO CCK8 AND FOOD-INTAKE IN RATS
    OROURKE, MF
    REIDELBERGER, RD
    SOLOMON, TE
    GASTROENTEROLOGY, 1988, 94 (05) : A620 - A620
  • [33] Long-term blockade of cholecystokinin (CCK): Effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion
    Rodriguez, AI
    Manso, MA
    GarciaMontero, AC
    Orfao, A
    deDios, I
    PANCREAS, 1997, 15 (03) : 314 - 322
  • [34] Aliphatic substitution of a transmembrane residue of the CCK2 receptor determines partial vs. inverse agonist activity of L-364,718
    Pratt, J
    Chen, C
    Beinborn, M
    Kopin, AS
    FASEB JOURNAL, 2000, 14 (08): : A1352 - A1352
  • [35] EFFECT OF INTRACEREBROVENTRICULAR AND SYSTEMIC INJECTIONS OF CERULEIN, A CCK ANALOG, ON ELECTRICAL SELF-STIMULATION AND ITS INTERACTION WITH THE CCKA RECEPTOR ANTAGONIST, L-364,718 (MK-329)
    HAMILTON, MH
    ROSE, IC
    HERBERG, LJ
    DEBELLEROCHE, JS
    PSYCHOPHARMACOLOGY, 1990, 101 (03) : 384 - 389
  • [36] COMBINATION EFFECT OF CCK RECEPTOR ANTAGONIST (L-364,718) AND 5-FLUOROURACIL (5-FU) ON THE GROWTH OF HUMAN PANCREATIC-CARCINOMA CELLS CULTURED IN-VITRO
    SONG, SY
    CHUNG, JB
    KANG, JK
    PARK, IS
    GASTROENTEROLOGY, 1995, 108 (04) : A540 - A540
  • [37] EFFECT OF A NEW CHOLECYSTOKININ RECEPTOR ANTAGONIST LOXIGLUMIDE ON ACUTE-PANCREATITIS IN 2 EXPERIMENTAL ANIMAL-MODELS
    TANI, S
    OKABAYASHI, Y
    NAKAMURA, T
    FUJII, M
    ITOH, H
    OTSUKI, M
    PANCREAS, 1990, 5 (03) : 284 - 290
  • [38] EFFECTS OF THE SELENOORGANIC SUBSTANCE EBSELEN IN 2 DIFFERENT MODELS OF ACUTE-PANCREATITIS
    NIEDERAU, C
    UDE, K
    NIEDERAU, M
    LUTHEN, R
    STROHMEYER, G
    FERRELL, LD
    GRENDELL, JH
    PANCREAS, 1991, 6 (03) : 282 - 290
  • [39] STUDIES OF PANCREATIC EXOCRINE SECRETION USING L364-718, A POTENT NEW ORALLY EFFECTIVE CCK RECEPTOR ANTAGONIST
    ROWELL, WG
    SCOTT, MP
    CURINGTON, CW
    TOSKES, PP
    GASTROENTEROLOGY, 1987, 92 (05) : 1712 - 1712
  • [40] COMPARISON OF THE EFFECTS OF THE CHOLECYSTOKININ-B RECEPTOR ANTAGONIST, PD-134308, AND THE CHOLECYSTOKININ-A RECEPTOR ANTAGONIST, L-364,718, ON DOPAMINE NEURONAL-ACTIVITY IN THE SUBSTANTIA-NIGRA AND VENTRAL TEGMENTAL AREA
    MELTZER, LT
    CHRISTOFFERSEN, CL
    SERPA, KA
    RAZMPOUR, A
    SYNAPSE, 1993, 13 (02) : 117 - 122
12345